Augmedix Stock Price To Book
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Augmedix fundamentals help investors to digest information that contributes to Augmedix's financial success or failures. It also enables traders to predict the movement of Augmedix Stock. The fundamental analysis module provides a way to measure Augmedix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Augmedix stock.
Augmedix |
Augmedix Company Price To Book Analysis
Augmedix's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Augmedix Price To Book | 11.09 X |
Most of Augmedix's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Augmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Augmedix has a Price To Book of 11.0899 times. This is 56.82% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The price to book for all United States stocks is 16.61% lower than that of the firm.
Augmedix Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Augmedix's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics of similar companies.Augmedix is currently under evaluation in price to book category among its peers.
Augmedix Fundamentals
| Return On Equity | -3.3 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (0.46) % | |||
| Operating Margin | (0.64) % | |||
| Current Valuation | 113.21 M | |||
| Shares Outstanding | 49.43 M | |||
| Shares Owned By Insiders | 1.50 % | |||
| Shares Owned By Institutions | 84.78 % | |||
| Number Of Shares Shorted | 1.07 M | |||
| Price To Book | 11.09 X | |||
| Price To Sales | 2.25 X | |||
| Revenue | 44.85 M | |||
| Gross Profit | 13.95 M | |||
| EBITDA | (17.68 M) | |||
| Net Income | (19.17 M) | |||
| Cash And Equivalents | 29.99 M | |||
| Cash Per Share | 0.80 X | |||
| Total Debt | 25.85 M | |||
| Debt To Equity | 1.54 % | |||
| Current Ratio | 2.89 X | |||
| Book Value Per Share | 0.21 X | |||
| Cash Flow From Operations | (15.44 M) | |||
| Short Ratio | 5.73 X | |||
| Earnings Per Share | (0.47) X | |||
| Target Price | 2.92 | |||
| Number Of Employees | 1.43 K | |||
| Beta | -0.19 | |||
| Market Capitalization | 116.16 M | |||
| Total Asset | 66.71 M | |||
| Retained Earnings | (144.96 M) | |||
| Working Capital | 33.2 M | |||
| Net Asset | 66.71 M |
About Augmedix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Augmedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Augmedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Augmedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |